Here are the biggest Dutch deals of Q1 2025:
40% off TNW Conference!
Leyden Labs is another biotech startup from Leiden home to one of Europes leading life science hubs.
The company is developing intranasal medicines to protect against respiratory viruses.
Vivici is a Dutch foodtech startup using precision fermentation to produce animal-free dairy proteins.
Its proteins are designed to replace traditional dairy ingredients like whey and casein.
Quantware designs and manufactures superconducting quantum processors.
Deep tech startupThorizonis developing modular molten salt reactors (MSRs) that utilise long-lived nuclear waste as fuel.
Varmx is a biotech startup developing a treatment to reverse bleeding in patients taking blood thinners.
Workwize provides cloud-based software for managing IT hardware in remote and hybrid workplaces.
Amsterdam-based Stacks provides an AI-driven platform that streamlines financial closing processes for businesses.
It marked the fifth consecutive quarter in which deal count has fallen.
Most striking is the sharp decline in later-stage funding.
Series B+ rounds halved from 14 in Q1 2024 to just seven this year.
In total, late-stage startups raised 287mn down an eye-watering 609mn from the previous year.
Early-stage startups, on the other hand, were a rare bright spot in an otherwise poor outlook.
Whats next?
The outlook for the rest of 2025 is mixed.
On the other hand, several issues are causing concern.
Not only did Europe lose its position internationally, but within Europe, the Netherlands is now losing importance.
Tickets for the event arenow on sale.
Use the code TNWXMEDIA2025 at the check-out to get 30% off the price tag.
Story bySion Geschwindt
Sion is a freelance science and technology reporter, specialising in climate and energy.
